SQSTM1/p62 as a prognostic indicator in pancancer and nasopharyngeal carcinoma.

BMC Res Notes · 2025 · PMC12502162 · PMID 41053894

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

borderline significanceP = 0.070so close (0.05 < p ≤ 0.1)

After adjusting for confounding variables, both high SQSTM1/P62 expression (HR = 3.53, 95% CI 1.16–10.74, P = 0.026) and older age (HR = 3.92, 95% CI 1.27–12.11, P = 0.017) retained independent prognostic significance, whereas adjuvant chemotherapy showed borderline significance (HR = 0.15, P = 0.070).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.